Send mail to Author

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____     __   __               ___     _    _      ___    
|  __ \\   \ \\/ //     ___     / _ \\  | |  | ||   / _ \\  
| |  \ ||   \ ` //     /   ||  | / \ || | |/\| ||  | / \ || 
| |__/ ||    | ||     | [] ||  | \_/ || |  /\  ||  | \_/ || 
|_____//     |_||      \__ ||   \___//  |_// \_||   \___//  
 -----`      `-`'       -|_||   `---`   `-`   `-`   `---`   
                         `-`
 


Back to frontdoor view

OPUS4 Logo